Introduction
Mln8237 (alisertib) is a selective aurora-a kinase inhibitor currently in clinical trials for hematopoietic neoplasms, neuroblastoma, ovarian cancer, melanoma and other solid tumors [1] [2] [3] [4] [5] . aurora-a is a serine-threonine kinase important in centrosome maturation and mitotic entry and exit [6] [7] [8] . Its inhibition is antiproliferative and leads to mitotic arrest, often resulting in tetraploidy, cellular senescence and/or apoptosis [3, 9, 10] . aurora-a kinase activity also affects multiple signaling pathways involved in growth and differentiation [11] [12] [13] [14] . aurora-a inhibitors thus represent a unique class of anti-neoplastic agents that act as classical direct inhibitors of cellular proliferation machinery and disruptors of kinase signaling pathways.
Because new therapies for gliomas continue to be urgently needed, we have pursued preclinical studies of Mln8237 as a potential chemotherapy agent against Abstract the selective aurora-a kinase inhibitor Mln8237 is in clinical trials for hematologic malignancies, ovarian cancer and other solid tumors. We previously showed that Mln8237 is potently antiproliferative toward standard monolayer-cultured glioblastoma cells. We have now investigated the effect of Mln8237 with and without temozolomide or ionizing radiation on the proliferation of glioblastoma tumor stem-like cells (neurospheres) using soft agar colony formation assays and normal human astrocytes by Mtt assay. Western blotting was utilized to compare Mln8237 IC 50 s to cellular aurora-a and phosphothr 288 aurora-a levels. Mln8237 was more potently antiproliferative to neurosphere cells than to standard monolayer glioma cells, and was non-toxic to normal human 1 3 glioblastoma. aurora-a kinase is variably overexpressed in gliomas and Mln8237 inhibits colony formation in standard glioblastoma cell lines [14] . Here, we show that Mln8237 also potently inhibits colony formation by neurosphere-forming glioblastoma tumor stem cells and is relatively non-toxic to normal human astrocytes. Mln8237 also inhibited aurora-a autophosphorylation at thr288 and its antiproliferative efficacy was partially predicted by phosphothr 288 aurora-a protein levels in vitro. additionally, we demonstrate that Mln8237 potentiates the effects of standard glioma treatments, i.e., temozolomide (tMZ) and radiation in glioblastoma monolayer and neurosphere stem cells.
Methods

neurosphere culture
Samples from resected brain tumors were collected at Henry Ford Hospital (Detroit, MI) with patient written consent in accordance with institutional guidelines, and histopathologically graded based on WHO criteria. glioblastoma tumors were dissociated, as previously described [15] . Dissociated cells were plated in t-25 flasks at a density of 2 × 10 4 cells/ml in neurosphere medium (nM): DMeM/F12 medium containing 2 mM l-glutamine and supplemented with n-2 (gibco Invitrogen Cell Culture, grand Island, nY), 0.05 % BSa, 25 μg/ml gentamicin, 50 units/ml penicillin g sodium, 50 μg/ml streptomycin sulfate, 20 ng/ml egF and 20 ng/ml bFgF (Peprotech, rocky Hills, nJ) and grown in standard conditions (5 % CO 2 /air at 37 °C). after 1-3 weeks, multicellular floating neurospheres formed and were dissociated in Mg
2+
-Ca 2+ -free PBS and replated in nM for the formation of secondary spheroids. glioblastoma neurospheres of <20 passages were used in experiments.
neurosphere cell colony formation in soft agar neurosphere cells established from two separate glioblastoma patient tumors were dissociated into single cells. a total of 1 × 10 4 cells were suspended in 0.3 % low melt agarose (Cambrex, rockland, USa) with DMSO alone or the investigational aurora-a inhibitor Mln8237 provided by Millennium Pharmaceuticals (Cambridge, Ma) diluted in DMSO with and without tMZ. Cells were then seeded on 0.5 % low melt agarose-precoated sixwell plates (Corning, Corning, nY, USa). a total volume of 4 ml medium was added on top of the agarose layer containing the cells. Medium was changed every 3 days. For drug treatments, both agarose layers and top medium were mixed with Mln8237 and/or tMZ. after 14 days of culture, the plates were stained by 0.05 % crystal violet for quantification of the colonies. Colonies with more than 20 cells were counted under an inverted light microscope. For radiation experiments, freshly plated cells with or without drugs were exposed to 1 gy or 2 gy of gamma radiation on the following day in a Jl Shepherd and associates Mark I-688 5000 Ci cesium (Cs-137) irradiator.
Monolayer glioblastoma cell colony formation assays established glioma monolayer cell lines were cultured in DMeM with 10 % fetal calf serum in 5 % CO 2 /air at 37 °C using standard methods. For colony formation assays, 600 cells were seeded per 60 mm dish and treated the following day with various concentrations of Mln8237 with and without tMZ in triplicate dishes for 72 h. Seven days later, the culture was aspirated and the dishes were washed with DPBS, fixed with methanol, stained with giemsa, rinsed in deionized water and air dried. Colonies containing 20 or more cells were counted using a dissecting microscope. Percent survival was calculated as the average number of colonies in 3 dishes for a given drug concentration time point divided by the average number of colonies in 3 untreated control dishes.
Cell proliferation assays normal human astrocytes (Invitrogen) were plated in 96-well plates at 3,000 cells per well, and cells were treated with the indicated concentration of Mln8237 or with DMSO vehicle in triplicate wells. after 3 days, 10 μl of 5 mg/ml Mtt reagent (roche) was added per well and plates were incubated four additional hours. One volume of cell solubilizing solution was added and the plate was incubated overnight to allow crystals to dissolve. absorbance at was read 570 nm on a BMg labtech Omega plate reader.
Western blotting
Cell pellets were suspended in rIPa buffer (thermo Scientific, rockford, Il)] containing 1 μM dithiothreitol and protease inhibitors [16 μg/ml aprotinin, 1 μg/ml each of leupeptin a, pepstatin and chymostatin (Sigma, St louis, MO) and 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride (MP Biomedicals, Solon, OH)] and centrifuged at 16,100×g at 4 °C for 20 min. lysate total protein was determined using the Pierce BCa method (thermo Scientific). lysates (10 μg) were electrophoresed on 10 % polyacrylamide gels and electrotransferred to Imobilon™ PVDF membranes (Millipore, Billerica, Ma). Membranes were blocked with 4 % dried milk in tris-buffered saline with 0.1 % tween-20 (tBSt) and incubated with clone 35C1 anti-human aurora-a antibody (abcam ab13824, 1:500), rabbit anti-human phosphothr 288 aurora-a (abcam ab58494, 1:500), or mouse monoclonal anti-β-actin (Sigma a2228, 1:4,000) for 90 min at room temperature. Secondary antibodies were goat anti-mouse or goat anti-rabbit Igg-HrP (Santa Cruz Biotechnologies, Santa Cruz, Ca) incubated for 30 min. Blots were developed with Pierce eCl (thermo Scientific) and exposed to X-ray film. ratios of aurora-a protein signal to β-actin signal within samples were determined by densitometry using nIH Image J software.
rt-PCr real-time PCr for aurora-a was performed using aBI taqMan (applied Biosystems) and a roche lightCycler 480. the internal control gene was β2-microglobulin. Primers and reaction conditions were as previously described [14] .
Statistics
Data are expressed as the mean ± the standard deviation. Colony count data were examined statistically using a Poisson regression model while Western blot and cell proliferation assays were examined using anOVa models with the response transformed to the log scale. a probability value of p < 0.05 was considered statistically significant between two groups. residual plots from each analysis did not show violations of underlying assumptions.
Results
Mln8237 potently inhibits neurosphere colony formation of cultured glioblastoma tumor stem-like cells
We previously showed that Mln8237 is cytotoxic for traditional monolayer glioma cell lines, with IC 50 's ranging from 60 to 225 nM for ten cell lines in clonogenic assays [14] . glioma cells cultured as neurospheres in a defined medium have been shown to have stem celllike properties, and to represent a better model of glioma than traditional serum-grown monolayer cells [15] [16] [17] [18] . therefore, we tested the effects of Mln8237 against colony formation by tumor stem cell neurosphere cultures from human patient tumors. Continuous Mln8237 exposure potently inhibited colony formation by HF2303SP and HF2587SP neurosphere tumor stem cells in soft agar with IC 50 's of approximately 5.9 and 2.8 nM, respectively (Fig. 1) .
Mln8237 is not significantly toxic to normal human astrocytes to examine whether Mln8237 has toxicity toward normal astrocytes, cultured human astrocytes were exposed to Mln8237 concentrations of up to 800 nM and metabolically active cells were quantitated by Mtt assay. Concentrations of Mln8237 up to 200 nM caused no decrease in Mtt metabolism compared with control untreated cells (Fig. 2) . even 800 nM resulted in little measured toxicity (10 %). [MLN8237] nM [MLN8237] nM Number of colonies Number of colonies
Mln8237 decreases aurora-a phosphorylation and is partially predicted by phosphothr 288 aurora-a levels in glioblastoma cells in vitro In order to begin to investigate the determinants of glioblastoma cell sensitivity to aurora-a, we performed quantitative western blotting for total aurora-a and phosphothr 288 aurora-a in glioblastoma cell lines (Fig. 3) . treatment for U251 glioblastoma cells with Mln8237 decreased phospho-aurora-a levels by approximately fourfold (Fig. 3a) . total aurora-a protein levels showed low correlation with Mln8237 IC 50 's in glioblastoma cell lines r = 0.55 (confidence intervals −0.12, 0.88) and was not significant (p = 0.0975).
aurora-a mrna levels as measured by rt-PCr showed virtually no correlation to Mln8237 potency (data not shown). In contrast, phosphothr 288 aurora-a protein levels showed moderate correlation with Mln8237 IC 50 's, r = 0.70 (0.12, 0.92) and was statistically significant (p = 0.0244) (Fig. 3c) . although these results provide evidence that phosphothr 288 aurora-a levels are relevant to Mln8237 sensitivity, the only moderate correlation (r = 0.70) suggests that other factors may be important in determining cell susceptibility to Mln8237.
Mln8237 antiproliferative activity is synergistic with temozolomide in cultured glioblastoma cells
We first investigated this question using standard monolayer glioblastoma tumor cell lines by colony formation assays. We previously showed that the IC 50 for inhibition of U87 glioblastoma cell colony formation by Mln8237 is approximately 100 nM [14] . Concentrations at and above the IC 50 (100-200 nM) substantially potentiated inhibition of U87 colony formation by tMZ (Fig. 4) . In addition, concentrations of Mln8237 as low as 12.5 nM, which did not significantly affect colony formation by U87 alone, significantly enhanced inhibition of colony formation by tMZ, suggesting a synergistic effect of low concentrations of Mln8237 with tMZ on these cells. In U251 cells, 100 nM or higher Mln8237 potentiated the effect of tMZ on colony formation in an additive fashion (Fig. 4) . Similar effects were seen on cell proliferation as measured by Mtt assay (Fig. 4c) . Both Mln (anOVa p < 0.001) and tMZ (p < 0.001) were associated with statistically significant reductions in cell proliferation by the Mtt assay. the effects of Mln8237 and tMZ are essentially additive with tMZ reducing the measured values by about 46 % at each Mln8237 dose level except at the highest dose where there may not have been enough to measure accurately (41 % dose 0; 42 % dose 0.01; 52 % dose 0.05; 49 % dose 0.1; and 7 % at dose 1). against HF2303SP glioblastoma neurosphere stem cells, 10 nM Mln8237 potentiated the effects of 100-200 nM tMZ (Fig. 5) . In HF2587SP neurosphere cells, Mln8237 was synergistic with tMZ (p ≈ 0.006). these effects were seen at much lower concentrations of Mln8237 (1-10 nM) with glioblastoma neurosphere cells, in comparison with monolayer glioma cells, in agreement with the greater sensitivity of neurosphere cells to Mln8237 seen above.
Mln8237 potentiates ionizing radiation in neurosphere tumor stem cells in vitro
We previously demonstrated that Mln8237 potentiated the effects of ionizing radiation in glioblastoma monolayer cell lines. For HF2303SP cells, low dose Mln8237 (10 nM) potentiated the effect of radiation on glioblastoma neurosphere cell colony formation in the range of exposure tested (2-6 gy). there was a statistically significant effect of both Mln8237 (p ≈ 0.0003) and radiation (p < 0.0001) with Mln8237 reducing colony counts by about 55 % and radiation reducing the number of colonies by about 75 per gy over this range. For HF2587SP cells, a similar low toxicity Mln8237 concentration of 2 nM was synergistic with radiation at measurable doses (1-2 gy) (Fig. 6) . there was a statistically significant effect of both Mln8237 (p ≈ 0.001) and radiation (p < 0.0001) with Mln8237 reducing colony counts by about 40 % and radiation having an approximate linear effect in the square root of the dose.
Discussion
glioblastoma is an aggressive tumor with a poor prognosis for which novel approaches to clinical treatment are critically needed. tumor stem cells represent the self renewing component of tumors and are thus an important target of therapy. Yet such tumor stem cells are also more resistant to chemotherapy and radiation compared with other tumor cells. thus, the potential usefulness of an anti-cancer strategy hinges on its efficacy against tumor stem cells. We have previously demonstrated that the selective aurora-a inhibitor Mln8237 potently inhibits colony formation of established and low-passage primary monolayer glioblastoma cell lines, and also potentiated the effects of ionizing radiation in these lines [14] .
Monolayer tumor cell lines represent a mixed culture of tumor cells. In monolayer glioblastoma cultures, tumor stem cells quickly revert to a more differentiated, non-stem-like state under standard adherent cell culture conditions including fetal calf serum [15] [16] [17] [18] . Culture of glioblastoma tumor cells freshly isolated from patient surgical samples in serum-free media selects for tumor stem cells which grow in spherical conglomerations called neurospheres, similar to normal brain stem cells. Here, we demonstrate that Mln8237 is also antiproliferative and potently inhibits colony formation of glioblastoma neurosphere stem cells, but showed no toxicity toward normal human astrocytes. Surprisingly, Mln8237 antiproliferative activity was even more potent in the glioblastoma tumor stem cells compared with monolayer cells, and is achieved at Mln8237 concentrations selective for auroraa kinase and below those in which inhibition of aurora-B kinase was reported to occur, approximately 1,500 nM in Hela cells [4] . Preclinical studies of Mln8237's efficacy in pediatric tumor xenograft models found correlation of drug efficacy with lower aurora-a gene copy numbers. We found some correlation of Mln8237 potency with glioblastoma cell aurora-a levels and better, yet still limited correlation with phospho-aurora-a levels. these findings suggest that other factors such as aurora-a interacting proteins [19] [20] [21] [22] or downstream targets of aurora-a kinase signaling [11] [12] [13] [14] are important in drug response.
Mln8237 antiproliferative activity also potentiated the activity of the standard clinical anti-glioma agent tMZ in either an additive or synergistic fashion in monolayer and neurosphere tumor stem cells. When we similarly looked at Mln8237's ability to potentiate ionizing radiation in neurosphere tumor stem cells, we found that Mln8237 was synergistic with ionizing radiation at low dosages. Similar additive potentiation or synergy with tMZ or radiation has been found with the combined aurora-a and aurora-B inhibitor ZM447439 against primary and standard glioblastoma monolayer cell lines [23] . Mln8237 has also been found to sensitize atypical teratoid rhabdoid tumor cells to radiation [24] .
these in vitro studies support that Mln8237 is a potentially effective adjunctive therapy against glioblastoma alone or in combination with other agents, such as tMZ, and/or may be useful as a biochemical sensitizer to radiation therapy. We are currently testing these possibilities in a mouse orthotopic glioblastoma xenograft model to further was then added to cell culture medium and the culture continued for 14 days (*p < 0.05; **p < 0.01, compared with no Mln8237 treatment)
